About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Erlotinib (Oral Route)
Drug Information provided by: MicromedexUS Brand Names
|
Description
Erlotinib belongs to the group of medicines called antineoplastics. It is used for the treatment and maintenance therapy of advanced or metastatic (cancer that has already spread) non-small cell lung cancer after the failure of other chemotherapy treatment. It is also used together with another medicine called gemcitabine (e.g., Gemzar®) to treat cancer of the pancreas.
This medicine is available only with your doctor's prescription.
Find Mayo Clinic on